MedTrace Logo

Botulinum Toxin Type A and Kinesitherapy of Post-stroke Patients

NCT00999180 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-12-15

No results posted yet for this study

Summary

The objective of this study is to assess if the association of botulinum toxin type A and kinesitherapy is superior to kinesitherapy and 0,9% saline for the functional performance in post-stroke patients.

Hypothesis H(0): BT-A associated to kinesitherapy is not superior to kinesitherapy in the function of hemiparetic post-stroke patients.

H(1): BT-A associated to kinesitherapy is superior to kinesitherapy in the function of hemiparetic post-stroke patients.

Conditions

Interventions

PROCEDURE

Botulinum toxin type A and kinesiotherapy

Stroke, Botulinum Toxin

PROCEDURE

Saline and Kinesiotherapy

Saline and Kinesiotherapy

Sponsors & Collaborators

  • Federal University of Bahia

    lead OTHER

Principal Investigators

  • Ailton Melo, PHD · Federal University of Bahia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-03-31
Completion
2012-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00999180 on ClinicalTrials.gov